reports
Veeco Books Multi-System Lumina and Spector Orders for Manufacturing I...
Veeco Books Multi-System Lumina and Spector Orders for Manufacturing Indium-Phosphide (InP) based Optical Components Company’s MOCVD and IBD technologies are crucial for optical transceiver manufacturing to support the growing AI server market PLAINVIEW, N.Y., March 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: VECO) today announced that a global leader in optical communications laser manufacturing placed orders for multiple Lumina® Metal Organic Chemical Vapor Deposition (MOCVD) systems and multiple Spector® Ion Beam Sputtering (IBD) Optical Coating systems. These tools will be used to fabric...
The Boston Beer Company Expands Sinless Vodka Cocktails to 34 Markets
The Boston Beer Company Expands Sinless Vodka Cocktails to 34 Markets Full-flavor, guilt-free vodka cocktails to reach even more drinkers with bold new look Boston, March 02, 2026 (GLOBE NEWSWIRE) -- is expanding its 2025 innovation into additional markets this spring, bringing even more drinkers this full-flavored, spirits-based cocktail with zero sugar, zero carbs, and zero compromise. Crafted for guilt-free good times, Sinless rolls into 34 states with a bold new look and personality that delivers on drinkers’ expectations. Sinless Vodka Cocktails Takes the Guilt Out of Good T...
Turnover of Apranga Group in February 2026
Turnover of Apranga Group in February 2026 The retail turnover (including VAT) of Apranga Group amounted to EUR 22.0 million in February 2026 and increased by 4.9% compared to February 2025. In January-February 2026, the retail turnover of Apranga Group (including VAT) totalled EUR 50.3 million and increased by 7.2% year-on-year. In January-February 2026, the retail turnover of Apranga Group in Lithuania increased by 7.9%, in Latvia increased by 5.4% and in Estonia increased by 7.6% year-on-year. Currently Apranga Group operates the chain of 172 stores (103 in Lithuania, 44 in Latvia and...
„Aprangos” grupės apyvarta 2026 m. vasario mėnesį
„Aprangos” grupės apyvarta 2026 m. vasario mėnesį „Aprangos“ grupės tinklo mažmeninė prekių apyvarta (su PVM) 2026 m. vasario mėnesį sudarė 22,0 mln. eurų ir buvo 4,9% didesnė nei 2025 m. vasario mėnesio apyvarta. 2026 m. sausio-vasario mėnesiais „Aprangos“ grupės tinklo mažmeninė prekių apyvarta (su PVM) sudarė 50,3 mln. eurų, arba 7,2% daugiau nei 2025 metų atitinkamu laikotarpiu. „Aprangos“ grupės tinklo apyvarta 2026 m. sausio-vasario mėnesiais, lyginant su atitinkamu 2025 metų laikotarpiu, Lietuvoje augo 7,9%, Latvijoje didėjo 5,4%, o Estijoje padidėjo 7,6%. Šiuo metu „Aprangos“ gru...
Cuentas Inc. Subsidiary World Mobile LLC Launches U.S. MVNO Cellular S...
Cuentas Inc. Subsidiary World Mobile LLC Launches U.S. MVNO Cellular Services for Subscribers of Hallo 015 Traveling or Residing in the United States Miami Beach, FL, March 02, 2026 (GLOBE NEWSWIRE) -- Cuentas Inc. (OTCQB: CUEN), a leading integrated communications, entertainment, and lifestyle platform company, today announced that its 51%-owned subsidiary, World Mobile LLC, has initiated Mobile Virtual Network Operator (MVNO) cellular services in the United States for customers of Israel-based mobile carrier Hallo 015 who are traveling to or living in the U.S. The new cross-border mob...
STEALTHGAS INC. Reports Fourth Quarter and Twelve Months 2025 Financia...
STEALTHGAS INC. Reports Fourth Quarter and Twelve Months 2025 Financial and Operating Results ATHENS, Greece, March 02, 2026 (GLOBE NEWSWIRE) -- STEALTHGAS INC. (NASDAQ: GASS), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today its unaudited financial and operating results for the fourth quarter and twelve months ended December 31, 2025. OPERATIONAL AND FINANCIAL HIGHLIGHTS In 2025 the Company maintained its high profitability reporting Net Income of $60.6 million and EPS of $1.64.For the fourth quarter Net inco...
Globex Options Joutel North-West and Gagne Gold Properties to Edison L...
Globex Options Joutel North-West and Gagne Gold Properties to Edison Lithium Corp. TORONTO, March 02, 2026 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to announce that Globex has entered an Option agreement with Edison Lithium Corp. (EDDY-TSXV, EDDYF-OTC PINK, VVO-FWB) (Edison) on Globex gold properties, Joutel North-West gold and Gagne gold and copper for ...
Schouw & Co. share buy-back programme, week 9 2026
Schouw & Co. share buy-back programme, week 9 2026 On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules). Trading dayNo. of sh...
Tenable to Host EXPOSURE 2026: The First Global Conference Devoted to ...
Tenable to Host EXPOSURE 2026: The First Global Conference Devoted to Exposure Management for the AI Era Global cybersecurity leaders will gather in Boston to define the future of proactive defense COLUMBIA, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Tenable® Holdings, Inc. (NASDAQ: TENB), the , today announced , the first global conference fully dedicated to exposure management in the AI era. The event will take place May 19-21, 2026 in Boston. has become essential as organizations confront the largest expansion of the attack surface in decades. Deeply embedded AI tools and highly conne...
SAB BIO to Participate in Upcoming Investor Conferences
SAB BIO to Participate in Upcoming Investor Conferences MIAMI, March 02, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: ), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that members of its management team will participate in the following investor conferences in March: Leerink Partners Global Healthcare ConferenceDate: March 9, 2026Time: 3:00 p.m. ETFormat: Location: Miami Beach, FL Barclays 28th Annual Global Healthcare ConferenceDate: March ...
Palisade Bio Announces Participation in Two Upcoming Investor Conferen...
Palisade Bio Announces Participation in Two Upcoming Investor Conferences Carlsbad, CA, March 02, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today announced that management will participate in two upcoming investor conferences taking place during March 2026. Details are as follows: Date/time: March 2, 2026 at 3:10 PM ESTLocation: Boston Mariott Copley Place, Boston, MA...
Northann Corp. Announces NYSE American's Acceptance of its Strategic L...
Northann Corp. Announces NYSE American's Acceptance of its Strategic Listing Optimization Plan Fort Lawn, SC, March 02, 2026 (GLOBE NEWSWIRE) -- Northann Corp. (NYSE American: NCL) (the "Company"), a technology innovator and producer of sustainable, natural material-based products for interior finishes, today announced that on February 24, 2026, it received an official notification from the NYSE American LLC (the “NYSE American”) accepting the Company’s strategic plan to regain compliance with the NYSE American’s listing standards . This acceptance letter granted the Company until June 8,...
AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clin...
AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer OCALA, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) today announced an agreement with the PPD™ clinical research business of Thermo Fisher Scientific to design AIM’s anticipated Phase 3 clinical trial in the use of the Company’s drug Ampligen in the treatment of late-stage pancreatic cancer. AIM CEO Thomas K. Equels states: “The ongoing Phase 2 DURIPANC clinical trial of Ampligen and AstraZeneca’s durvalum...
Oncolytics Biotech® Launches Randomized Colorectal Cancer Study
Oncolytics Biotech® Launches Randomized Colorectal Cancer Study Controlled study designed to confirm previous compelling efficacy with preliminary data expected by the end of 2026 Pelareorep-based treatment regimen recently granted Fast Track Designation in 2L KRAS-mutant MSS metastatic colorectal cancer, confirming its potential in this large indication SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced the initiation of a metastatic colorect...
JAKKS Pacific and Aniplex of America Extend Partnership to Distribute ...
JAKKS Pacific and Aniplex of America Extend Partnership to Distribute an Array of All-New Demon Slayer: Kimetsu no Yaiba Toys and Collectibles SANTA MONICA, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK), a leading global manufacturer of toys and consumer products, and its costume division, Disguise, announced today the extension of its partnership with Aniplex Inc. to distribute a new line of Demon Slayer: Kimetsu no Yaiba costumes, toys, collectibles, and accessories. Under this expanded partnership, Disguise will continue to distribute Demon Slayer: Kimet...
BOS Announces Two U.S. Customer Orders Totaling $2 Million
BOS Announces Two U.S. Customer Orders Totaling $2 Million Continues to expand contracted backlog and U.S. presence RISHON LE ZION, Israel, March 02, 2026 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. ("BOS" or the "Company") (NASDAQ: BOSC), an integrator of supply chain technologies for the aerospace, defense, industrial and retail sectors, announced today that it has received two new orders totaling $2 million from two United States based customers. The orders are expected to be delivered over the next 12 months. Avidan Zelicovski, BOS President, said: "These two orders, for $...
Arqit and RAD announce Quantum-Safe collaboration Against Evolving Cyb...
Arqit and RAD announce Quantum-Safe collaboration Against Evolving Cyberthreats LONDON, March 02, 2026 (GLOBE NEWSWIRE) -- Arqit (Nasdaq: ARQQ, ARQQW), a global leader in PQC migration tooling and quantum-safe encryption, and RAD, a global leader in networking edge solutions, today announced a collaboration to deliver a joint quantum-safe encryption solution for telcos, enabling them to offer quantum-safe business services such as site-to-site and site-to-cloud VPNs, as well as Data Center Interconnect (DCI). This announcement follows the successful integration of Arqit’s NetworkSecure™ q...
Actelis Networks Wins Order for Caltrans, California Department of Tra...
Actelis Networks Wins Order for Caltrans, California Department of Transportation, Highway Modernization in San Mateo County, California Company Continues Streak of States, Counties, and Cities Adopting Actelis' Hybrid Fiber-Copper Networking Solutions Sunnyvale, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today announced that it has received an order to supply its hybrid fiber-copper networking solution in suppor...
Commerce Split Corp. Announces Capital Share Split and Increased Distr...
Commerce Split Corp. Announces Capital Share Split and Increased Distributions TORONTO, March 02, 2026 (GLOBE NEWSWIRE) -- Commerce Split Corp. (the “Company”) is pleased to announce its intention to complete a share split of its Capital Shares (the “Share Split”) and to increase the targeted distributions payable on the Capital Shares, reflecting the strong performance of the Company. Capital shareholders of record at the close of business on March 6, 2026 will receive 10 additional Capital Shares for every 100 Capital Shares held, pursuant to the Share Split. The Share Split is subject...
Shift4 Payments Inc: 1 director
A director at Shift4 Payments Inc bought 296,237 shares at 46.106USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.